share_log

Neumora Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-ARCH Venture Fund VII, L.P.(20.9%),ARCH Venture Fund VIII Overage, L.P.(20.9%), etc.

Neumora Therapeutic | SC 13D/A:超过5%持股股东披露文件(修正)-ARCH Venture Fund VII, L.P.(20.9%),ARCH Venture Fund VIII Overage, L.P.(20.9%)等

美股sec公告 ·  2023/12/15 17:06
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息